As of 2024-12-12, the EV/EBITDA ratio of Cell Impact AB (publ) (CI.ST) is -1.84. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CI.ST's latest enterprise value is 142.42 mil SEK. CI.ST's TTM EBITDA according to its financial statements is -77.27 mil SEK. Dividing these 2 quantities gives us the above CI.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.0x - 15.0x | 14.0x |
| Forward P/E multiples | 14.0x - 15.6x | 15.2x |
| Fair Price | (1.58) - (1.69) | (1.65) |
| Upside | -982.1% - -1047.9% | -1020.6% |
| Date | EV/EBITDA |
| 2024-11-20 | -1.84 |
| 2024-11-19 | -1.83 |
| 2024-11-18 | -1.81 |
| 2024-11-15 | -1.88 |
| 2024-11-14 | -1.85 |
| 2024-11-13 | -1.77 |
| 2024-11-12 | -1.84 |
| 2024-11-11 | -1.79 |
| 2024-11-08 | -1.93 |
| 2024-11-07 | -1.96 |
| 2024-11-06 | -1.96 |
| 2024-11-05 | -2.03 |
| 2024-11-04 | -2.04 |
| 2024-11-01 | -2.04 |
| 2024-10-31 | -2.08 |
| 2024-10-30 | -2.08 |
| 2024-10-29 | -2.16 |
| 2024-10-28 | -2.16 |
| 2024-10-25 | -2.12 |
| 2024-10-24 | -2.12 |
| 2024-10-23 | -2.22 |
| 2024-10-22 | -2.26 |
| 2024-10-21 | -2.07 |
| 2024-10-18 | -2.11 |
| 2024-10-17 | -2.08 |
| 2024-10-16 | -2.12 |
| 2024-10-15 | -2.21 |
| 2024-10-14 | -2.21 |
| 2024-10-11 | -2.23 |
| 2024-10-10 | -2.16 |
| 2024-10-09 | -2.19 |
| 2024-10-08 | -2.34 |
| 2024-10-07 | -2.45 |
| 2024-10-04 | -2.58 |
| 2024-10-03 | -2.66 |
| 2024-10-02 | -2.67 |
| 2024-10-01 | -2.48 |
| 2024-09-30 | -2.57 |
| 2024-09-27 | -2.35 |
| 2024-09-26 | -2.19 |
| 2024-09-25 | -2.03 |
| 2024-09-24 | -2.04 |
| 2024-09-23 | -1.99 |
| 2024-09-20 | -1.99 |
| 2024-09-19 | -2.11 |
| 2024-09-18 | -2.19 |
| 2024-09-17 | -2.15 |
| 2024-09-16 | -2.09 |
| 2024-09-13 | -2.21 |
| 2024-09-12 | -2.34 |